Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price target among analysts that have covered the stock in the last year is $92.00.

ACHC has been the topic of a number of recent research reports. Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price on the stock in a research note on Friday, January 5th. Barclays assumed coverage on Acadia Healthcare in a research note on Wednesday, March 6th. They set an “overweight” rating and a $100.00 price target for the company. UBS Group upped their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. TheStreet upgraded Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Finally, TD Cowen upped their price target on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st.

Acadia Healthcare Stock Up 3.1 %

NASDAQ:ACHC opened at $73.38 on Friday. The business’s fifty day moving average price is $78.45 and its 200 day moving average price is $77.67. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 1-year low of $66.49 and a 1-year high of $87.77. The firm has a market capitalization of $6.78 billion, a price-to-earnings ratio of -293.51, a PEG ratio of 2.09 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million for the quarter, compared to the consensus estimate of $727.60 million. During the same quarter in the previous year, the company posted $0.70 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. On average, sell-side analysts forecast that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 2.80% of the stock is owned by corporate insiders.

Institutional Trading of Acadia Healthcare

Several hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after purchasing an additional 30,296 shares during the period. Wellington Management Group LLP raised its holdings in Acadia Healthcare by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock valued at $529,991,000 after acquiring an additional 152,783 shares in the last quarter. William Blair Investment Management LLC raised its holdings in Acadia Healthcare by 0.3% in the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock valued at $215,072,000 after acquiring an additional 10,062 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Acadia Healthcare by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock valued at $88,482,000 after acquiring an additional 13,765 shares in the last quarter. Finally, Avidity Partners Management LP raised its holdings in Acadia Healthcare by 61.8% in the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after acquiring an additional 441,692 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.